EDITAS MEDICINE INC.
3.1500
07-November-24 12:54:43
15 minutes delayed
Stocks
-0.1300
-3.96%
Today's range
3.1100 - 3.3000
ISIN
N/A
Source
NASDAQ
-
Editas Medicine Announces First Quarter 2022 Results and Business Updates
04 May 2022 05:45:00 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2022 Results and Corporate Update
27 Apr 2022 05:55:00 By Nasdaq GlobeNewswire
-
26 Apr 2022 08:00:03 By Nasdaq GlobeNewswire
-
Editas Medicine Appoints Gilmore O’Neill as Chief Executive Officer
14 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2022 08:00:00 By Nasdaq GlobeNewswire
-
08 Apr 2022 12:00:00 By Nasdaq GlobeNewswire
-
28 Feb 2022 15:01:00 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Fourth Quarter and Full Year 2021 Results and Business Updates
24 Feb 2022 05:30:00 By Nasdaq GlobeNewswire
-
16 Feb 2022 05:15:00 By Nasdaq GlobeNewswire
-
Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
10 Jan 2022 06:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference
04 Jan 2022 05:58:00 By Nasdaq GlobeNewswire
-
20 Dec 2021 06:00:00 By Nasdaq GlobeNewswire
-
12 Dec 2021 17:00:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine Announces Third Quarter 2021 Results and Business Updates
08 Nov 2021 06:00:01 By Nasdaq GlobeNewswire
-
Editas Medicine Names Bernadette Connaughton to Board of Directors
28 Oct 2021 08:00:02 By Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
25 Oct 2021 15:01:00 By Nasdaq GlobeNewswire